Methylphenidate Controlled-Release Tablets and Signifor (Pasireotide Extended-Release Injection)
Determining the interaction of Methylphenidate Controlled-Release Tablets and Signifor (Pasireotide Extended-Release Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Controlled-Release Tablets-Signifor (Pasireotide Injection)
- Methylphenidate Controlled-Release Tablets-Signifor Injection
- Methylphenidate Controlled-Release Tablets-Signifor LAR
- Methylphenidate Controlled-Release Tablets-Signifor LAR Injection
- Methylphenidate Controlled-Release Tablets-Siklos
- Methylphenidate Controlled-Release Tablets-Siladryl Allergy
- Signifor (Pasireotide Extended-Release Injection)-Methylphenidate ER Capsules
- Signifor (Pasireotide Extended-Release Injection)-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Signifor (Pasireotide Extended-Release Injection)-Methylphenidate Extended-Release Chewable Tablets
- Signifor (Pasireotide Extended-Release Injection)-Methylphenidate Extended-Release Oral Suspension
- Signifor (Pasireotide Extended-Release Injection)-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Signifor (Pasireotide Extended-Release Injection)-Methylphenidate Extended-Release Tablets